How much funding has Celldex Therapeutics raised?

Celldex Therapeutics has raised $300.0M in total funding, most recently a Venture Round.

When was Celldex Therapeutics founded?

Celldex Therapeutics was founded in 1983.

Where is Celldex Therapeutics headquartered?

Celldex Therapeutics is headquartered in HAMPTON, New Jersey, United States.

What industry is Celldex Therapeutics in?

Celldex Therapeutics operates in Biotech, Healthcare.

How many employees does Celldex Therapeutics have?

Celldex Therapeutics has 51-200 employees.

Celldex Therapeutics

IPO

Pioneering new horizons in immunology

Public · HAMPTON, United States · Founded 1983 · $300.0M raised

Biotech

Healthcare

Headquarters: HAMPTON, New Jersey
Employees: 51–200
Founded: 1983
Business Model: B2B
Website: celldex.com

Total Funding: $300.0M
Last Round: $300.0M Venture RoundMar 2024
Rounds: 1
Type: Public

About

Celldex Therapeutics is a clinical-stage biopharmaceutical company pioneering novel antibody-based treatments that engage the human immune system to improve the lives of patients with allergic, inflammatory, and autoimmune disorders. Originally founded in 1983 as AVANT Immunotherapeutics and renamed Celldex Therapeutics in 2008 following a merger with private Celldex Therapeutics Inc., the company is headquartered in Hampton, New Jersey. Celldex focuses on advancing mast cell biology and developing therapeutic antibodies targeting conditions such as urticaria, atopic dermatitis, and other immunological diseases. The company is publicly traded on Nasdaq under the ticker symbol CLDX.

Summary

Celldex Therapeutics is a Biotech company based in HAMPTON, United States, founded in 1983. It has raised $300.0M in total across 1 round, most recently a $300.0M Venture Round round in Mar 2024.

LinkedIn X (Twitter)